Ventricular Assist Devices (VAD)

This channel includes news and new technology innovations for ventricular assist devices (VAD). VADs are a type of mechanical hemodynamic support device that helps increase blood flow in people who have ventricles that are not work properly due to heart failure, cardiogenic shock, cardiomyopathy or myocardial infarction. Most often these devices support the left ventricle, so they are often referred to as left ventricular assist devices (LVAD). VADS come in two types, surgically implanted, usually as a bridge to heart transplant, and percutanenous catheter-based pumps used for temporary hemodynamic support. Examples of temporary percutaneous pumps include the Impella and TandemHeart devices.

 

Pre-PCI Impella 2.5 Insertion Improves Survival in Left Main Coronary Artery Heart Attacks
News | Ventricular Assist Devices (VAD) | June 30, 2017

June 30, 2017 — Abiomed Inc. announced the recent publication of a peer-reviewed retrospective study on...

Italian Boy Becomes Youngest Patient Bridged to Transplant With SynCardia Total Artificial Heart

Andrei, 12, is the world’s youngest patient to be bridged to transplant with the SynCardia Total Artificial Heart. He is pictured after his heart transplant with his surgeon, Antonio Amodeo, M.D., at Bambino Gesù Children’s Hospital in Rome, Italy. Photo courtesy of Business Wire.

News | Congenital Heart | June 22, 2017

June 22, 2017 — A 12-year-old boy at Bambino Gesù Children’s Hospital in Rome, Italy, has become the world’s...

Abiomed Impella CP pVAD, third-generation CP
Technology | Hemodynamic Support Devices | June 12, 2017

June 12, 2017 — Abiomed Inc. recently released its third-generation Impella CP heart pump at the 2017 meeting of the...

tandemLife Tandemheart priming tray cleared by FDA
Technology | Hemodynamic Support Devices | June 12, 2017

June 12, 2017 — TandemLife began its commercial launch of the TandemLife Priming Tray, a new product designed to...

Videos | Cardiovascular Ultrasound | May 26, 2017

This video, provided in partnership with the American Society of Echocardiography (ASE), is titled "Intraoperative...

Impella CP study to investigate door to left ventricular unloading time
News | May 09, 2017

May 9, 2017 — The first patient has been enrolled in the U.S. Food and Drug Administration (FDA) approved...

Heartware HVAD recall for its ventricular assist device from Medtronic
Feature | Ventricular Assist Devices (VAD) | May 05, 2017

May 5, 2017 — Medtronic Mechanical Circulatory Support is expanding its recall of its HeartWare Ventricular Assist...

the Impella pVAD improves survival, mortality in AMI heart attack with cardiogenic shock

Early use of the Impella percutaneous ventricular assist device prior to angioplasty may significantly improve survival for patients in cardiogenic shock.

Feature | Hemodynamic Support Devices | April 28, 2017 | Dave Fornell

Recent clinical study data presented at the American College of Cardiology (ACC) 2017 meeting show new treatment...

Henry Ford Hospital, Detroit Cardiogenic Shock Initiative, Impella pump, ACC.17 clinical study
News | Ventricular Assist Devices (VAD) | April 03, 2017

April 3, 2017 — Hospitals can dramatically increase heart attack survival rates in patients suffering cardiogenic...

Videos | Hemodynamic Support Devices | March 21, 2017

This video, provided by Abiomed, demonstrates the Impella percutaneous ventricular assist devices (pVAD). It offers...

Metro Detroit cardiologists, increased heart attack survival rate, Impella heart pump, Detroit Cardiogenic Shock Initiative
News | Ventricular Assist Devices (VAD) | March 09, 2017

March 9, 2017 — Metro Detroit cardiologists from five health systems have joined together to increase residents’...

Abiomed, Impella heart pump, 50,000 patients treated, United States, milestone
News | Ventricular Assist Devices (VAD) | February 24, 2017

February 24, 2017 — Abiomed Inc. announced that it has supported more than 50,000 patients in the U.S. with its...

Overlay Init